Julie Voss
Overview
Explore the profile of Julie Voss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
AghaAmiri S, Simien J, Thompson A, Voss J, Ghosh S, Vargas S, et al.
Mol Imaging
. 2021 Jul;
2021:5540569.
PMID: 34194285
Background: Although therapeutic advances have led to enhanced survival in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, detection of residual disease remains challenging. Here, we examine...
2.
Vargas S, Lin C, AghaAmiri S, Voss J, Ikoma N, Tran Cao H, et al.
Proc SPIE Int Soc Opt Eng
. 2021 May;
11222.
PMID: 34054189
Introduction: The clinical need for improved intraoperative tumor visualization has led to the development of targeted contrast agents for fluorescence-guided surgery (FGS). A key characteristic of these agents is their...
3.
Vargas S, Lin C, Voss J, Ghosh S, Halperin D, AghaAmiri S, et al.
J Biomed Opt
. 2020 Dec;
25(12).
PMID: 33300316
Significance: The use of cancer-targeted contrast agents in fluorescence-guided surgery (FGS) has the potential to improve intraoperative visualization of tumors and surgical margins. However, evaluation of their translational potential is...
4.
Vargas S, Kossatz S, Voss J, Ghosh S, Tran Cao H, Simien J, et al.
Clin Cancer Res
. 2019 Apr;
25(14):4332-4342.
PMID: 31015345
Purpose: Clinically available intraoperative imaging tools to assist surgeons in identifying occult lesions are limited and partially responsible for the high rate of disease recurrence in patients with neuroendocrine tumors...
5.
Guenther C, Brun M, Bennett A, Ho M, Chen W, Zhu B, et al.
Mol Ther
. 2019 Feb;
27(3):611-622.
PMID: 30772143
Adeno-associated virus (AAV) has emerged as a promising gene delivery vector because of its non-pathogenicity, simple structure and genome, and low immunogenicity compared to other viruses. However, its adoption as...
6.
Azhdarinia A, Voss J, Ghosh S, Simien J, Vargas S, Cui J, et al.
Mol Pharm
. 2018 May;
15(6):2448-2454.
PMID: 29718672
Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) is highly expressed in colorectal tumors and marks colon cancer stem cells that drive tumor growth and metastasis. Recently, we showed that LGR5...
7.
Ghosh S, Vargas S, Rodriguez M, Kossatz S, Voss J, Carmon K, et al.
ACS Med Chem Lett
. 2017 Jul;
8(7):720-725.
PMID: 28740605
Fluorescently labeled imaging agents can identify surgical margins in real-time to help achieve complete resections and minimize the likelihood of local recurrence. However, photon attenuation limits fluorescence-based imaging to superficial...
8.
Ghosh S, Rodriguez M, Carmon K, Voss J, Wilganowski N, Schonbrunn A, et al.
J Nucl Med
. 2017 Jun;
58(11):1858-1864.
PMID: 28572490
Fluorescence-guided surgery is an emerging imaging technique that can enhance the ability of surgeons to detect tumors when compared with visual observation. To facilitate characterization, fluorescently labeled probes have been...